163 related articles for article (PubMed ID: 11911411)
1. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas.
Takenaka K; Shinagawa K; Maeda Y; Makita M; Kozuka T; Ashiba A; Yamamoto K; Fujii N; Nawa Y; Hiramatsu Y; Sunami K; Ishimaru F; Yoshimo T; Kiura K; Harada M
Leuk Lymphoma; 2001; 42(6):1297-303. PubMed ID: 11911411
[TBL] [Abstract][Full Text] [Related]
2. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Rodriguez J; Romaguera JE; Manning J; Ordonez N; Ha C; Ravandi F; Cabanillas F
Leuk Lymphoma; 2000 Sep; 39(1-2):139-44. PubMed ID: 10975392
[TBL] [Abstract][Full Text] [Related]
3. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation.
Nawa Y; Takenaka K; Shinagawa K; Deguchi S; Matsumura N; Koyama S; Hiramatsu Y; Omoto E; Yoshino T; Harada M
Bone Marrow Transplant; 1999 Jun; 23(12):1321-2. PubMed ID: 10414923
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.
Sanda T; Lida S; Ito M; Tsuboi K; Miura K; Harada S; Komatsu H; Wakita A; Inagaki H; Ueda R
Int J Hematol; 2002 Feb; 75(2):195-200. PubMed ID: 11939269
[TBL] [Abstract][Full Text] [Related]
6. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
[TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.
Bang SM; Kim YK; Park YH; Sohn SK; Lee JJ; Cho EK; Ryoo BY; Chung IJ; Yoon SS; Kim HJ; Lee JH; Yoon HJ; Park S
Leuk Lymphoma; 2005 Nov; 46(11):1599-1604. PubMed ID: 16334486
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.
Li M; Gao C; Li H; Wang Z; Cao Y; Huang W; Li X; Wang S; Yu L; Da W
Med Oncol; 2011 Sep; 28(3):840-5. PubMed ID: 20414818
[TBL] [Abstract][Full Text] [Related]
12. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
[TBL] [Abstract][Full Text] [Related]
14. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
17. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Park BB; Kim WS; Lee J; Park KW; Kang JH; Lee SH; Park JO; Kim K; Jung CW; Park YS; Im YH; Kang WK; Ko YH; Lee MH; Park K
Leuk Lymphoma; 2005 Dec; 46(12):1743-8. PubMed ID: 16263576
[TBL] [Abstract][Full Text] [Related]
18. CD56+ NK lymphomas: clinicopathological features and prognosis.
Kwong YL; Chan AC; Liang R; Chiang AK; Chim CS; Chan TK; Todd D; Ho FC
Br J Haematol; 1997 Jun; 97(4):821-9. PubMed ID: 9217183
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.
Sasaki M; Matsue K; Takeuchi M; Mitome M; Hirose Y
Int J Hematol; 2000 Jan; 71(1):75-8. PubMed ID: 10729998
[TBL] [Abstract][Full Text] [Related]
20. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.
Ribrag V; Ell Hajj M; Janot F; Girinsky T; Domenge C; Schwaab G; Fenaux P; Bosq J
Leukemia; 2001 Jul; 15(7):1123-6. PubMed ID: 11455983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
